Yawen Guo

1.4k total citations · 2 hit papers
51 papers, 1.0k citations indexed

About

Yawen Guo is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Yawen Guo has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Oncology. Recurrent topics in Yawen Guo's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Thyroid and Parathyroid Surgery (6 papers) and Inflammasome and immune disorders (5 papers). Yawen Guo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Thyroid and Parathyroid Surgery (6 papers) and Inflammasome and immune disorders (5 papers). Yawen Guo collaborates with scholars based in China, United States and Taiwan. Yawen Guo's co-authors include Tao Huang, Zeming Liu, Chunping Liu, Jiajie Xu, You-Ni Zhang, Xiaoyi Chen, Wen Zeng, Yusufu Maimaiti, Tianwen Chen and Shan Wang and has published in prestigious journals such as Advanced Materials, Energy & Environmental Science and PLoS ONE.

In The Last Decade

Yawen Guo

46 papers receiving 1.0k citations

Hit Papers

Metal nanoparticles as a promising technology in targeted... 2022 2026 2023 2024 2022 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yawen Guo China 18 326 205 179 142 141 51 1.0k
Dong Chul Kim South Korea 19 398 1.2× 154 0.8× 212 1.2× 102 0.7× 121 0.9× 87 1.2k
Masanori Fujimoto Japan 14 176 0.5× 76 0.4× 83 0.5× 40 0.3× 70 0.5× 40 748
Haiming Sun China 19 460 1.4× 48 0.2× 163 0.9× 38 0.3× 75 0.5× 67 1.0k
Han‐Yi Chou Taiwan 16 372 1.1× 25 0.1× 105 0.6× 133 0.9× 183 1.3× 34 825
Sheng Liu United States 22 759 2.3× 30 0.1× 343 1.9× 171 1.2× 61 0.4× 65 1.5k
Zhen Qin China 17 437 1.3× 29 0.1× 87 0.5× 140 1.0× 116 0.8× 45 803
Binbin Ma China 20 462 1.4× 33 0.2× 71 0.4× 124 0.9× 36 0.3× 53 1.1k
Eliza Głodkowska‐Mrówka Poland 15 275 0.8× 21 0.1× 56 0.3× 139 1.0× 88 0.6× 36 890
Sijia He China 13 522 1.6× 81 0.4× 150 0.8× 290 2.0× 19 0.1× 30 1.1k

Countries citing papers authored by Yawen Guo

Since Specialization
Citations

This map shows the geographic impact of Yawen Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawen Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawen Guo more than expected).

Fields of papers citing papers by Yawen Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawen Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawen Guo. The network helps show where Yawen Guo may publish in the future.

Co-authorship network of co-authors of Yawen Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yawen Guo. A scholar is included among the top collaborators of Yawen Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawen Guo. Yawen Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Yefeng, Yawen Guo, Pu Cheng, et al.. (2025). A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer. European Journal of Endocrinology. 192(2). 128–140.
2.
Wei, Nan, Hao Lu, Yaoyao Wei, et al.. (2025). Constructing a dual-fiber network in high efficiency organic solar cells via additive-induced supramolecular interactions with both donor and acceptor. Energy & Environmental Science. 18(5). 2298–2307. 21 indexed citations
3.
Guo, Yawen, et al.. (2025). Ambient Listening in Clinical Practice: Evaluating EPIC Signal Data Before and After Implementation and Its Impact on Physician Workload. Studies in health technology and informatics. 329. 653–657. 5 indexed citations
4.
Guo, Yawen, Lei Zhu, Yanting Duan, et al.. (2024). Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission. Cell Death and Disease. 15(2). 125–125. 19 indexed citations
5.
Guo, Yawen, Xiao Liu, Anjana Susarla, & Rema Padman. (2024). YouTube Videos for Public Health Literacy? A Machine Learning Pipeline to Curate Covid-19 Videos. Studies in health technology and informatics. 310. 760–764. 2 indexed citations
6.
Guo, Yawen, Fahuan Song, Lei Zhu, et al.. (2024). Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification. Cell Death and Disease. 15(8). 586–586. 8 indexed citations
9.
Tian, Li, Hu Tao, Yawen Guo, et al.. (2024). Architecturing ultra-stable multi-dimensional MXene/MAX self-supporting electrode anchored with Low-Pt for efficient hydrogen evolution reaction in harsh environments. Journal of Colloid and Interface Science. 679(Pt A). 411–419. 3 indexed citations
10.
Li, Yujie, et al.. (2023). A New Prenylated Isoflavone from the Stems of Harrisonia perforata. Chinese Journal of Organic Chemistry. 43(2). 771–771.
11.
Guo, Yawen, et al.. (2022). Public Opinions toward COVID-19 Vaccine Mandates: A Machine Learning-based Analysis of U.S. Tweets. PubMed Central. 4 indexed citations
12.
Cai, Yefeng, Yunye Liu, Qinglin Li, et al.. (2022). Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway. Phytomedicine. 108. 154528–154528. 59 indexed citations
13.
Zheng, Guibin, et al.. (2021). Safety and surgical outcomes of transoral endoscopic thyroidectomy vestibular approach for papillary thyroid cancer: A two-centre study. European Journal of Surgical Oncology. 47(6). 1346–1351. 17 indexed citations
14.
Chen, Chen, Yusufu Maimaiti, Zeming Liu, et al.. (2017). Slingshot-1L, a cofilin phosphatase, induces primary breast cancer metastasis. Oncotarget. 8(39). 66195–66203. 7 indexed citations
15.
Guo, Yawen, Pan Yu, Zeming Liu, et al.. (2017). Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis. PLoS ONE. 12(4). e0174843–e0174843. 17 indexed citations
16.
Liu, Zeming, Wen Zeng, Shi Wang, et al.. (2017). A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells.. PubMed. 9(7). 3212–3223. 35 indexed citations
17.
Maimaiti, Yusufu, Zeming Liu, Jie Tan, et al.. (2016). Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis. OncoTargets and Therapy. Volume 9. 6461–6466. 12 indexed citations
18.
Liu, Chunping, Zeming Liu, Tianwen Chen, et al.. (2016). TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis. Scientific Reports. 6(1). 36990–36990. 49 indexed citations
19.
Ming, Jie, Zeming Liu, Wen Zeng, et al.. (2015). Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.. PubMed. 8(11). 15155–62. 20 indexed citations
20.
Tian, Ye, Chong Lu, Hui Guo, et al.. (2014). Effects of notch-1 down-regulation on malignant behaviors of breast cancer stem cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(2). 195–200. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026